What is United Laboratories International Holdings Cash Flow from Financing?
Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.
For the
six
months ended in Jun. 2024,
United Laboratories International Holdings paidHK$0 Mil more to buy back shares than it received from issuing new shares.
It receivedHK$1,015 Mil from issuing more debt.
It paidHK$0 Mil more to buy back preferred shares than it received from issuing preferred shares.
It receivedHK$0 Mil from paying cash dividends to shareholders.
It receivedHK$33 Mil on other financial activities.
In all, United Laboratories International HoldingsearnedHK$1,047 Mil on financial activities for the
six
months ended in Jun. 2024.
United Laboratories International Holdings Cash Flow from Financing Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
United Laboratories International Holdings Cash Flow from Financing Chart
United Laboratories International Holdings Annual Data
United Laboratories International Holdings Cash Flow from Financing Calculation
This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.
Cash Flow from Financing for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$445 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
United Laboratories International Holdings (HKSE:03933) Cash Flow from Financing Explanation
Cash from financing contains six items:
1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.
United Laboratories International Holdings's issuance of stock for the
six
months ended in Jun. 2024 was HK$0 Mil.
2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.
United Laboratories International Holdings's repurchase of stock for the
six
months ended in Jun. 2024 was HK$0 Mil.
3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.
United Laboratories International Holdings's net issuance of debt for the
six
months ended in Jun. 2024 was HK$1,015 Mil.
United Laboratories International Holdings receivedHK$1,015 Mil from issuing more debt.
4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.
United Laboratories International Holdings's net issuance of preferred for the
six
months ended in Jun. 2024 was HK$0 Mil.
United Laboratories International Holdings paidHK$0 Mil more to buy back preferred shares than it received from issuing preferred shares.
5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
United Laboratories International Holdings's cash flow for dividends for the
six
months ended in Jun. 2024 was HK$0 Mil.
United Laboratories International Holdings receivedHK$0 Mil from paying cash dividends to shareholders.
6. Other Financing:
Money spent or earned by company from other financial activities.
United Laboratories International Holdings's other financing for the
six
months ended in Jun. 2024 was HK$33 Mil.
United Laboratories International Holdings receivedHK$33 Mil on other financial activities.
United Laboratories International Holdings Cash Flow from Financing Related Terms
Thank you for viewing the detailed overview of United Laboratories International Holdings's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.
United Laboratories International Holdings Business Description
United Laboratories International Holdings Ltd is a drug manufacturing company. United Laboratories is organized into three revenue streams, including Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Bulk medicine segment, followed by Finished products. Majority of the company's sales are generated in China, followed by Europe, India and other countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:03933 has been successfully added to your 